The cost-utility of aflibercept for the treatment of...

The cost-utility of aflibercept for the treatment of age-related macular degeneration compared to bevacizumab and ranibizumab and the influence of model parameters

Elshout, Mari, van der Reis, Margriet I., Webers, Carroll A. B., Schouten, Jan S. A. G.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
252
Language:
english
Journal:
Graefe's Archive for Clinical and Experimental Ophthalmology
DOI:
10.1007/s00417-014-2641-3
Date:
December, 2014
File:
PDF, 1.19 MB
english, 2014
Conversion to is in progress
Conversion to is failed